| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $402.1B | $372.8B | $357.8B | $322.5B | $292.1B | $268.7B | $66.9B | $54.4B |
| Cost of Revenue | $221.2B | $206.3B | $217.1B | $196.9B | $175.8B | $164.0B | $158.7B | $156.4B |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $4.7B | $8.5B | $13.7B | $7.7B | $13.2B | $13.9B | $3.0B | $0.8B |
| Net Income | $1.8B | $4.6B | $8.3B | $4.1B | $7.9B | $7.2B | $1.7B | $-0.4B |
| EPS (Basic) | $1.40 | $3.67 | $6.49 | $3.16 | $6.00 | $5.48 | $1.34 | $-0.37 |
| EPS (Diluted) | $1.39 | $3.66 | $6.47 | $3.14 | $5.95 | $5.46 | $1.33 | $-0.37 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $253.5B | $253.2B | $249.7B | $228.3B | $233.0B | $230.7B | $222.4B | $196.5B |
| Current Assets | $74.7B | $68.6B | $67.9B | $65.7B | $60.0B | $56.4B | $50.3B | $45.2B |
| Cash & Equivalents | $8.5B | $8.6B | $8.2B | $12.9B | $9.4B | $7.9B | $5.7B | $4.1B |
| Total Liabilities | $178.2B | $177.5B | $173.1B | $157.0B | $157.6B | $161.0B | $158.3B | $137.9B |
| Current Liabilities | $88.7B | $84.6B | $79.2B | $69.7B | $67.8B | $62.0B | $53.3B | $44.0B |
| Stockholders' Equity | $75.2B | $75.6B | $76.5B | $71.0B | $75.1B | $69.4B | $63.9B | $58.2B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $10.6B | $9.1B | $13.4B | $16.2B | $18.3B | $15.9B | $12.8B | $8.9B |
| Investing Cash Flow | $-5.9B | $-7.6B | $-20.9B | $-5.0B | $-5.3B | $-5.5B | $-3.3B | $-43.3B |
| Capital Expenditures | $2.8B | $2.8B | $3.0B | $2.7B | $2.5B | $2.4B | $2.5B | $2.0B |
| Financing Cash Flow | $-4.9B | $-1.1B | $2.7B | $-10.5B | $-11.4B | $-8.2B | $-7.8B | $36.8B |